Sign up to save your podcasts
Or
Share E48: ADACTA - Tocilizumab or Adalimumab in MTX Intolerant Patients with RA
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
E48: ADACTA - Tocilizumab or Adalimumab in MTX Intolerant Patients with RA
This week I revisit an old paper - the 2013 ADACTA trial that assessed tocilizumab and adalimumab for patients who cannot take or were intolerant of MTX.
View all episodes
By Michael Putman
4.9
111111 ratings
This week I revisit an old paper - the 2013 ADACTA trial that assessed tocilizumab and adalimumab for patients who cannot take or were intolerant of MTX.
More shows like The Evidence Based Rheumatology Podcast
View all
JAMA Clinical Reviews
494 Listeners
Rheumnow Podcast
117 Listeners
The Curbsiders Internal Medicine Podcast
3,320 Listeners
Core IM | Internal Medicine Podcast
1,081 Listeners
Healio Rheuminations
119 Listeners
The Clinical Problem Solvers
514 Listeners
ACR on Air
67 Listeners
Around the Rheum
5 Listeners
Rheumatology For The Royal College
170 Listeners
RheumMadness Podcast
11 Listeners
The Lancet Rheumatology in conversation with
0 Listeners
Talking Rheumatology Research
1 Listeners
Talking Rheumatology
0 Listeners
Talking Rheumatology Spotlight
5 Listeners
ACR Journals On Air
18 Listeners